New insights into spontaneous intestinal perforation using a national data set: (1) SIP is associated with early indomethacin exposure.
about
Evidence-based use of indomethacin and ibuprofen in the neonatal intensive care unitNew insights into spontaneous intestinal perforation using a national data set (3): antenatal steroids have no adverse association with spontaneous intestinal perforation.Emerging trends in acquired neonatal intestinal disease: is it time to abandon Bell's criteria?Role of human milk in extremely low birth weight infants' risk of necrotizing enterocolitis or death.Patent ductus arteriosus in premature infants: A never-closing act.Failure of a repeat course of cyclooxygenase inhibitor to close a PDA is a risk factor for developing chronic lung disease in ELBW infants.Pharmacological Closure of Patent Ductus Arteriosus: Selecting the Agent and Route of Administration.Effects of intravenous indomethacin on reduction of symptomatic patent ductus arteriosus cases and decreasing the need for prolonged mechanical ventilation.Prophylactic indomethacin and intestinal perforation in extremely low birth weight infants.Pharmacovigilance in children: detecting adverse drug reactions in routine electronic healthcare records. A systematic review.Repeated bowel perforations with Ibuprofen lysine: a case report.Comparative effectiveness and safety of indomethacin versus ibuprofen for the treatment of patent ductus arteriosus.Treatment strategies to prevent or close a patent ductus arteriosus in preterm infants and outcomes.Patent ductus arteriosus: lack of evidence for common treatments.Necrotizing enterocolitis during the first week of life: a multicentered case-control and cohort comparison study.Spontaneous intestinal perforation in extremely low birth weight infants: association with indometacin therapy and effects on neurodevelopmental outcomes at 18-22 months corrected age.Understanding intestinal vulnerability to perforation in the extremely low birth weight infant.Patent ductus arteriosus in the preterm infant: to treat or not to treat?Gastrointestinal complications associated with ibuprofen therapy for patent ductus arteriosus.Recent developments in necrotizing enterocolitis.Prolonged persistent patent ductus arteriosus: potential perdurable anomalies in premature infants.Managing the patent ductus arteriosus: current treatment options.Management of Shock in Neonates.Intestinal perforation in the premature infant.Risk factors and prevention for surgical intestinal disorders in extremely low birth weight infants.Intestinal perforation in very preterm neonates: risk factors and outcomes.Intestinal Perforation during the Stabilization Period in a Preterm Infant with Congenital Diaphragmatic Hernia.Hydrocortisone administration for the treatment of refractory hypotension in critically ill newborns.Long-distance air medical transport of extremely low birth weight infants with pneumoperitoneum.Effect of prophylactic indomethacin administration and early feeding on spontaneous intestinal perforation in extremely low-birth-weight infants.Risk factors for spontaneous localized intestinal perforation in the preterm infant.Indomethacin prophylaxis or expectant treatment of patent ductus arteriosus in extremely low birth weight infants?Enteral water for hypernatremia and intestinal morbidity in infants less than or equal to 1000 g birth weight.The effects of indomethacin tocolysis on the postnatal response of the ductus arteriosus to indomethacin in extremely low birth weight infants.Prenatal or postnatal indomethacin exposure and neonatal gut injury associated with isolated intestinal perforation and necrotizing enterocolitis.Management of neonatal spontaneous intestinal perforation by peritoneal needle aspiration.Clinical implication of spontaneous gastrointestinal perforation in pediatric patients: its difference according to age group
P2860
Q24604121-77A57E84-F190-4657-8D63-12A5CD124F11Q30441808-EABB58CE-E62D-4ED3-892D-1429171E5585Q30443994-74B57BA9-6F3D-409F-9244-782C22A0D746Q33570420-87DBEEAD-7D71-4C8C-A902-3732EEE5532FQ34030439-A570E9C6-D9BC-4C25-BC13-D047063B49D3Q34143373-67CCB42D-888F-4C59-A233-8DBAF3A48E31Q34517223-428AC8E4-9031-46EC-A8D3-A8EA88D91C48Q34925657-24485819-219F-4162-83A4-018A93235CE2Q35943172-2EFBF7D7-E620-48F8-9BEF-685835775B10Q36125536-C7F7EBBC-B469-4718-B812-862A09037B16Q36290720-E9A7526C-AFDC-454B-BECA-D4ABA72718D6Q36327648-E861F170-A130-4990-8615-D6BF14A7B036Q36717942-04AA5DE0-E526-4BA6-84C0-58CC14075967Q36977136-B076639A-3B98-425E-9A52-18245755B51EQ37119717-CDEA914F-3328-4164-8F71-CFD76AA56733Q37122613-F2D98949-E2D5-45EC-BA7E-105832FD8D58Q37267187-3A479044-8F18-4F75-BC8C-5E9DD6451346Q37793846-DEF5E103-E829-455C-9AAA-D13B0F5AF948Q37831102-71F96F50-FB88-4093-B96A-80D9F81DD239Q37975157-50D61404-9151-4386-9512-D38F26EB2AFEQ37998378-652FBFA1-050E-4939-8502-F6266C6E37E3Q38218037-DE0A8633-345B-44B6-9171-DCE36CB880FCQ38492171-3B514D8C-1A19-46E9-8505-CDD1F3757DDCQ38602057-3FE09B62-1D9B-48E8-B400-2FA63375E124Q38909567-359932CF-54EB-4C30-A067-8BE8EE3840AEQ41270708-A80BD56B-D01B-43E2-B822-66FB1D844DEAQ41578995-53A6BFB7-BF4A-4B11-9A5F-237C15F4350AQ46704612-60632D9C-A471-4F11-9CD3-F31E3A3E4521Q47244893-ACBE7147-0934-4252-BDCB-5FF6E3DC95BAQ47265707-29E6EA42-1090-4BC3-A07E-8C7983293F86Q47279017-24F442B6-8933-4A06-BE3E-C0F8B71CC076Q47304334-E994B0AF-4CC0-4DB4-9B80-28DB99ADCD3BQ47309065-711AF737-D1BD-440B-8574-7F24FF48D1D1Q47316789-EF27DB10-E1D1-4ED9-8051-CB9F7E4F352AQ48228247-AE4408DD-5053-43A9-8CEF-97A2319E99CEQ50096110-7E89BE73-B980-444E-8B0F-5ED2D7965283Q58781724-3C2B461E-422F-40C9-AC18-A2B36EB2F486
P2860
New insights into spontaneous intestinal perforation using a national data set: (1) SIP is associated with early indomethacin exposure.
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
New insights into spontaneous ...... h early indomethacin exposure.
@ast
New insights into spontaneous ...... h early indomethacin exposure.
@en
type
label
New insights into spontaneous ...... h early indomethacin exposure.
@ast
New insights into spontaneous ...... h early indomethacin exposure.
@en
prefLabel
New insights into spontaneous ...... h early indomethacin exposure.
@ast
New insights into spontaneous ...... h early indomethacin exposure.
@en
P2093
P2860
P356
P1476
New insights into spontaneous ...... h early indomethacin exposure.
@en
P2093
P2860
P2888
P356
10.1038/SJ.JP.7211429
P577
2006-02-01T00:00:00Z
P5875
P6179
1052819490